2023 Form 5500 filing — Sumitovant Biopharma, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241009105137NAL0010538691001) for Sumitovant Biopharma, Inc. 401(K) Plan, reported by Sumitovant Biopharma, Inc. under EIN 84-3508458 and plan number 001. It reports 646 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241009105137NAL0010538691001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Sumitovant Biopharma, Inc.
- EIN
- 84-3508458
- Plan number
- 001
- Location
- New York, NY
- Participants
- 646
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $0
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $0
- Employer contributions
- $5,335,772
- Participant contributions
- $7,489,622
- Total income / additions
- $21,412,131
- Benefits paid
- $1,077,392
- Administrative expenses
- $105,070
- Total expenses
- $1,185,976
- Net increase / (decrease)
- $20,226,155
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Nfp | INVESTMENT ADVISOR | $64,000 | not reported in the loaded dataset |
| Fidelity Investments Institutional | RECORDKEEPER | $41,070 | $0 |